Found: 47
Select item for more details and to access through your institution.
Phase I Study on the Sequential Administration of Recombinant Human Interferon-γ and Recombinant Human Interleukin-2 in Patients With Metastatic Solid Tumors.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1991, v. 83, n. 19, p. 1408, doi. 10.1093/jnci/83.19.1408
- By:
- Publication type:
- Article
Stage, treatment and survival of low‐grade serous ovarian carcinoma in the Netherlands: A nationwide study.
- Published in:
- Acta Obstetricia et Gynecologica Scandinavica, 2023, v. 102, n. 3, p. 246, doi. 10.1111/aogs.14518
- By:
- Publication type:
- Article
Frozen section diagnosis of borderline ovarian tumors with suspicious features of invasive cancer is a devil's dilemma for the surgeon: A systematic review and meta‐analysis.
- Published in:
- Acta Obstetricia et Gynecologica Scandinavica, 2021, v. 100, n. 8, p. 1369, doi. 10.1111/aogs.14105
- By:
- Publication type:
- Article
Short-term surgical complications after radical hysterectomy-A nationwide cohort study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Transcriptional Activity and Stability of CD39+CD103+CD8+ T Cells in Human High-Grade Endometrial Cancer.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 11, p. 3770, doi. 10.3390/ijms21113770
- By:
- Publication type:
- Article
Tumor infiltrating CD8/CD103/ TIM-3-expressing lymphocytes in epithelial ovarian cancer coexpress CXCL13 and associate with improved survival.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1031746
- By:
- Publication type:
- Article
Induction and characterization of cytotoxic T-lymphocytes recognizing a mutated p21ras peptide presented by HLA-A*0201.
- Published in:
- International Journal of Cancer, 1995, v. 61, n. 3, p. 389, doi. 10.1002/ijc.2910610319
- By:
- Publication type:
- Article
Tertiary lymphoid structures critical for prognosis in endometrial cancer patients.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29040-x
- By:
- Publication type:
- Article
Targeted delivery of CD40L promotes restricted activation of antigen-presenting cells and induction of cancer cell death.
- Published in:
- Molecular Cancer, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-4598-13-85
- By:
- Publication type:
- Article
Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1454, doi. 10.1007/s10637-020-00920-7
- By:
- Publication type:
- Article
ImmunoPET provides a novel way to visualize the CD103<sup>+</sup> tissue-resident memory T cell to predict the response of immune checkpoint inhibitors.
- Published in:
- EJNMMI Research, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13550-023-01062-6
- By:
- Publication type:
- Article
Development of [<sup>89</sup>Zr]Zr-hCD103.Fab01A and [<sup>68</sup>Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET.
- Published in:
- EJNMMI Research, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13550-023-01043-9
- By:
- Publication type:
- Article
Galectin-9 Activates and Expands Human T-Helper 1 Cells
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0065616
- By:
- Publication type:
- Article
Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: an observational cohort study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Inclusion of the benefits of enhanced crossprotection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.
- Published in:
- BMC Infectious Diseases, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2334-13-75
- By:
- Publication type:
- Article
Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 3, p. 449, doi. 10.1007/s00262-008-0583-5
- By:
- Publication type:
- Article
Homologous Recombination Deficiency and Cyclin E1 Amplification Are Correlated with Immune Cell Infiltration and Survival in High-Grade Serous Ovarian Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5965, doi. 10.3390/cancers14235965
- By:
- Publication type:
- Article
Expression of CD39 Identifies Activated Intratumoral CD8+ T Cells in Mismatch Repair Deficient Endometrial Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 1924, doi. 10.3390/cancers14081924
- By:
- Publication type:
- Article
Alphavirus-based Vaccines Encoding Nonstructural Proteins of Hepatitis C Virus Induce Robust and Protective T-cell Responses.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 4, p. 881, doi. 10.1038/mt.2013.287
- By:
- Publication type:
- Article
B cells critical for outcome in high grade serous ovarian carcinoma.
- Published in:
- International Journal of Cancer, 2024, v. 155, n. 12, p. 2265, doi. 10.1002/ijc.35149
- By:
- Publication type:
- Article
Distinct regulation and impact of type 1 T-cell immunity against HPV16 L1, E2 and E6 antigens during HPV16-induced cervical infection and neoplasia.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 3, p. 675, doi. 10.1002/ijc.21394
- By:
- Publication type:
- Article
Strong vaccine responses during chemotherapy are associated with prolonged cancer survival.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 535, p. 1, doi. 10.1126/scitranslmed.aaz8235
- By:
- Publication type:
- Article
Therapeutic immunization and local low-dose tumor irradiation, a reinforcing combination.
- Published in:
- International Journal of Cancer, 2014, v. 134, n. 4, p. 859, doi. 10.1002/ijc.28418
- By:
- Publication type:
- Article
Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: A phase I/II clinical trial.
- Published in:
- International Journal of Cancer, 2013, v. 132, n. 7, p. 1581, doi. 10.1002/ijc.27819
- By:
- Publication type:
- Article
Loss of HLA class I and mismatch repair protein expression in sporadic endometrioid endometrial carcinomas.
- Published in:
- International Journal of Cancer, 2012, v. 131, n. 8, p. 1828, doi. 10.1002/ijc.27449
- By:
- Publication type:
- Article
Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: A single-arm phase II study.
- Published in:
- International Journal of Cancer, 2012, v. 131, n. 5, p. E670, doi. 10.1002/ijc.27388
- By:
- Publication type:
- Article
Long-term clinical and immunological effects of p53-SLP® vaccine in patients with ovarian cancer.
- Published in:
- International Journal of Cancer, 2012, v. 130, n. 1, p. 105, doi. 10.1002/ijc.25980
- By:
- Publication type:
- Article
The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer.
- Published in:
- International Journal of Cancer, 2010, v. 126, n. 6, p. 1417, doi. 10.1002/ijc.24852
- By:
- Publication type:
- Article
Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial.
- Published in:
- International Journal of Cancer, 2009, v. 125, n. 9, p. 2104, doi. 10.1002/ijc.24597
- By:
- Publication type:
- Article
Prognostic benefit of TILs independent of clinicopathological and molecular factors.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 7, p. 1360, doi. 10.1038/s41416-023-02141-0
- By:
- Publication type:
- Article
Tumour-infiltrating lymphocytes: from prognosis to treatment selection.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 3, p. 451, doi. 10.1038/s41416-022-02119-4
- By:
- Publication type:
- Article
Multi-parametric profiling of renal cell, colorectal, and ovarian cancer identifies tumour-type-specific stroma phenotypes and a novel vascular biomarker.
- Published in:
- Journal of Pathology: Clinical Research, 2017, v. 3, n. 3, p. 214, doi. 10.1002/cjp2.74
- By:
- Publication type:
- Article
Rapid and efficient generation of antigen‐specific isogenic T cells from cryopreserved blood samples.
- Published in:
- Immunology & Cell Biology, 2022, v. 100, n. 4, p. 285, doi. 10.1111/imcb.12538
- By:
- Publication type:
- Article
Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open Questions.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 3, p. 200, doi. 10.3390/cells8030200
- By:
- Publication type:
- Article
Equity in human papilloma virus vaccination uptake?: sexual behaviour, knowledge and demographics in a cross-sectional study in (un)vaccinated girls in the Netherlands.
- Published in:
- BMC Public Health, 2014, v. 14, n. 1, p. 288, doi. 10.1186/1471-2458-14-288
- By:
- Publication type:
- Article
Equity in human papilloma virus vaccination uptake?: sexual behaviour, knowledge and demographics in a cross-sectional study in (un)vaccinated girls in the Netherlands.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Comparatively low attendance during Human Papillomavirus catch-up vaccination among teenage girls in the Netherlands: Insights from a behavioral survey among parents.
- Published in:
- BMC Public Health, 2012, v. 12, n. 1, p. 498, doi. 10.1186/1471-2458-12-498
- By:
- Publication type:
- Article
From Tumor Immunosuppression to Eradication: Targeting Homing and Activity of Immune Effector Cells to Tumors.
- Published in:
- Clinical & Developmental Immunology, 2011, p. 1, doi. 10.1155/2011/439053
- By:
- Publication type:
- Article
Potential Target Antigens for a Universal Vaccine in Epithelial Ovarian Cancer.
- Published in:
- Clinical & Developmental Immunology, 2010, p. 1, doi. 10.1155/2010/891505
- By:
- Publication type:
- Article
Lymphadenectomy and Adjuvant Therapy Improve Survival with Uterine Carcinosarcoma: A Large Retrospective Cohort Study.
- Published in:
- Oncology, 2018, v. 95, n. 2, p. 100, doi. 10.1159/000488531
- By:
- Publication type:
- Article
Genomic instability as a driver and suppressor of anti-tumor immunity.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1462496
- By:
- Publication type:
- Article
Borderline ovarian tumor frozen section diagnoses with features suspicious of invasive cancer: a retrospective study.
- Published in:
- Journal of Ovarian Research, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13048-021-00897-8
- By:
- Publication type:
- Article
Association of homozygous variants of STING1 with outcome in human cervical cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 1, p. 61, doi. 10.1111/cas.14680
- By:
- Publication type:
- Article
In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.
- Published in:
- European Journal of Immunology, 1993, v. 23, n. 9, p. 2072, doi. 10.1002/eji.1830230905
- By:
- Publication type:
- Article
Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes.
- Published in:
- European Journal of Immunology, 1993, v. 23, n. 6, p. 1215, doi. 10.1002/eji.1830230603
- By:
- Publication type:
- Article